We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPATH.L Regulatory News (PATH)

  • There is currently no data for PATH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Subscription for £55,000 of Convertible Loan Stock

3 Dec 2020 09:44

RNS Number : 4343H
Path Investments plc
03 December 2020
 

 

Path Investments plc("Path" or the "Company")

 

Subscription for £55,000 of Convertible Unsecured Loan Stock

 

Path Investments plc (TIDM: PATH), the energy and natural resources investment company, announces that certain investors, including directors of the Company, have subscribed for £55,000 of the Company's 2018 nominal convertible unsecured loan stock instrument, as described in the Company's 2018 Annual Report.

 

The directors who have participated are Brent Fitzpatrick and Jack Allardyce, who have each subscribed for £5,000. In addition, Ocean Park Developments, a company ultimately owned by Mr Fitzpatrick has subscribed for £5,000. The funds raised will be applied towards the costs of the Company's proposed re-Admission, as announced on 5 November 2020.

 

The notification set out below, made pursuant to Article 19(3) of the Market Abuse Regulation, provides further details.

 

1.

Details of Director/PDMR

(a)

Name

Brent Fitzpatrick

2.

Reason for notification

(b)

Position / status

Chairman

 

(c)

Initial notification / amendment

Initial notification

3.

Details of the Issuer

(a)

Name

Path Investments plc

(b)

LEI

21380058VQBP76M7TN11

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) have been conducted

(a)

Description of the financial instrument, type of instrument, Identification code

Ordinary shares of 0.1 pence each

ISIN GB00BYQD5059

PATH

(b)

Nature of the transaction

Subscription pursuant to the Company's 2018 nominal convertible unsecured loan stock instrument

(c)

Price(s) and volume

Price

Volume

Nil

n/a

 

 

(d)

Aggregated information

N/A (single transaction)

(e)

Date of the transaction

2.12. 2020

(f)

Place of the transaction

Outside of trading venue

 

1.

Details of Director/PDMR

(a)

Name

Jack Allardyce

2.

Reason for notification

(b)

Position / status

Executive Director

 

(c)

Initial notification / amendment

Initial notification

3.

Details of the Issuer

(a)

Name

Path Investments plc

(b)

LEI

21380058VQBP76M7TN11

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) have been conducted

(a)

Description of the financial instrument, type of instrument, Identification code

Ordinary shares of 0.1 pence each

ISIN GB00BYQD5059

PATH

(b)

Nature of the transaction

Subscription pursuant to the Company's 2018 nominal convertible unsecured loan stock instrument

(c)

Price(s) and volume

Price

Volume

Nil

n/a

 

 

(d)

Aggregated information

N/A (single transaction)

(e)

Date of the transaction

2.12.2020

(f)

Place of the transaction

Outside of trading venue

 

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014.

 

For further information please contact:

Path Investments plc

C/O IFC

Christopher Theis

IFC Advisory Limited (Financial PR & IR)

020 3934 6630

Tim Metcalfe

Zach Cohen

Grant Thornton UK LLP (Financial Adviser)

Jamie Barklem

020 7865 2692

Harrison Clarke

020 7184 4384

Keith, Bayley, Rogers & Co. Limited (Broker)

Brinsley Holman

07776 30 22 28

Graham Atthill-Beck

07506 43 41 07

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCTJBLTMTJMMLM
Date   Source Headline
7th Apr 20227:00 amRNSUpdate on Acquisition
5th Apr 20227:00 amRNSInvestor Presentation
1st Apr 20222:45 pmRNSResult of General Meeting
14th Mar 20221:09 pmRNSPublication of Prospectus, Notice of GM, Fundraise
1st Feb 20227:00 amRNSProposed Transaction Update
31st Dec 20217:00 amRNSProposed Transaction Update
18th Nov 20217:00 amRNSAppointment of Joint Broker
26th Oct 20217:00 amRNSProposed Transaction Update
13th Oct 20216:02 pmRNSCorrection: Holding(s) in Company
13th Oct 20214:52 pmRNSHolding(s) in Company
11th Oct 20217:00 amRNSBlock listing Interim Review
29th Sep 20217:00 amRNSInterim Results for the six months to 30 June 2021
28th Sep 20212:45 pmRNSResult of AGM
22nd Sep 20212:41 pmRNSFurther secured loan provided to DG Innovate
9th Sep 20216:01 pmRNSHolding(s) in Company
2nd Sep 20217:00 amRNSNotice of AGM
18th Aug 202111:54 amRNSCorrection: Holding(s) in Company
18th Aug 20217:00 amRNSHolding(s) in Company
13th Aug 20217:45 amRNSProposed Acquisition of DG Innovate & Suspension
14th Jul 20215:23 pmRNSHolding(s) in Company
14th Jul 20212:39 pmRNSHolding(s) in Company
24th Jun 20217:00 amRNSFinal Results for the Year Ended 31 December 2020
16th Jun 20217:00 amRNSHolding(s) in Company
8th Jun 202111:49 amRNSHolding(s) in Company
7th Jun 202112:04 pmRNSHolding(s) in Company
9th Apr 202110:03 amRNSHolding(s) in Company
9th Apr 20217:00 amRNSBlock Listing
1st Apr 20215:02 pmRNSHolding(s) in Company
31st Mar 20219:55 amRNSTotal Voting Rights
24th Mar 20212:06 pmRNSDirector/PDMR Share Transaction
19th Mar 20218:53 amRNSHolding(s) in Company
12th Mar 20215:36 pmRNSAdmission of previously issued shares
12th Mar 202112:50 pmRNSPublication of Prospectus
8th Mar 202111:05 amRNSSecond Price Monitoring Extn
8th Mar 202111:00 amRNSPrice Monitoring Extension
1st Mar 20214:41 pmRNSSecond Price Monitoring Extn
1st Mar 20214:36 pmRNSPrice Monitoring Extension
26th Feb 20212:06 pmRNSSecond Price Monitoring Extn
26th Feb 20212:00 pmRNSPrice Monitoring Extension
26th Feb 20217:00 amRNSEquity Fundraise Update
19th Feb 20217:00 amRNS£3.5 million Equity Fundraise
15th Feb 20212:00 pmRNSTermination of DTU Acquisition
3rd Dec 20209:44 amRNSSubscription for £55,000 of Convertible Loan Stock
5th Nov 20207:00 amRNSFurther re the Acquisition of 75% of DT Ultravert
8th Oct 20209:55 amRNSOption Surrender and Issue of Replacement Options
5th Oct 20207:00 amRNSProposed sale of Kansas Land Leases and equipment
1st Oct 202011:41 amRNSFurther re the Acquisition of DT Ultravert
30th Sep 20207:00 amRNSBoard Changes & Acquisition of Deferred Shares
10th Sep 20201:30 pmRNSInterim Results for the six months to 30 June 2020
10th Sep 20201:15 pmRNSFinal Results for the Year Ended 31 December 2019

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.